The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.

Scariano, John K; Treat, Eric; Alba, Frances; Nelson, Harold; Ness, Scott A; Smith, Anthony Y

Scariano, John K; Treat, Eric; Alba, Frances; Nelson, Harold; Ness, Scott A; Smith, Anthony Y.

Affiliation

Scariano JK; Department of Pathology and Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131-0001, USA.

Prostate ; 68(16): 1798-805, 2008 Dec 01.

Article in En | MEDLINE | ID: mdl-18780294

Subject(s)

3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics; Adenocarcinoma/genetics; Polymorphism, Single Nucleotide/genetics; Prostatic Neoplasms/genetics; Severity of Illness Index; Age of Onset; Aged; Aged, 80 and over; Case-Control Studies; Disease Progression; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease/genetics; Genotype; Humans; Male; Middle Aged; Pilot Projects; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / 3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Severity of Illness Index / Adenocarcinoma / Polymorphism, Single Nucleotide Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Prostate Year: 2008 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google